SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000875320-17-000023
Filing Date
2017-03-06
Accepted
2017-03-06 16:52:07
Documents
2
Effectiveness Date
2017-03-06

Document Format Files

Seq Description Document Type Size
1 8-K concert8-k.htm DEFA14A 21581
2 EXHIBIT 99.1 vertex_concertxprx03032017.htm EX-99.1 23986
  Complete submission text file 0000875320-17-000023.txt   46538
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19319 | Film No.: 17668524
SIC: 2834 Pharmaceutical Preparations